Skip to content

FP7H2020HORIZONEDF

Universitaet Ulm

Country
DEGermany
Defence projects
1
Projects, all programmes
209
As coordinator
40
EU contribution (CORDIS)
EUR 109,353,275
Active
2008 to 2025

Projects

209 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
NEWTBVACDiscovery and preclinical development of new generation tuberculosis vaccinesFP72010ParticipantEUR 425,800
PERSPaediatric European Risperidone StudiesFP72010ParticipantEUR 368,960
REMODELLINGATP dependent nucleosome remodelling - Single molecule studies and super-resolution microscopyFP72009CoordinatorEUR 869,062
SHELTERServices and Health for Elderly in Long TERm careFP72009ParticipantEUR 223,620
MEMORY QUANTUM ICTINFORMATION TRANSFER WITH CORRELATED NOISE AND MEMORY EFFECTS IN QUANTUM COMMUNICATION TECHNOLOGIESFP72009CoordinatorEUR 160,997
ALLEGROEarly and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapyFP72009ParticipantEUR 99,000
CEDARClinical decision making and outcome in routine care for people with severe mental illnessFP72009CoordinatorEUR 503,371
CASCADECultivated Adult Stem Cells as Alternative for Damaged tissueFP72009ParticipantEUR 142,798
MITOTARGETMitochondrial dysfunction in neurodegenerative diseases: towards new therapeuticsFP72009ParticipantEUR 194,239
ELCATSurface Electrochemical Reactivity in Electrocatalysis: A combined Theoretical and Experimental ApproachFP72008ParticipantEUR 364,261
EU-PACTA pharmacogenomic approach to coumarin anticoagulant therapyFP72008ParticipantEUR 154,858
PRECIOSAPrivacy Enabled Capability In co-Operative systems and Safety ApplicationsFP72008ParticipantEUR 290,448
INEFInhibiting Nef: a novel drug target for HIV-host interactionsFP72008ParticipantEUR 471,600
HIPHYBRID INFORMATION PROCESSINGFP72008ParticipantEUR 161,000
TINNEvaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonatesFP72008ParticipantEUR 100,000
GENODISCDisc-degeneration linked pathologies: novel biomarkers and diagnostics for targeting treatment and repairFP72008ParticipantEUR 258,720
APO-SYSApoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicineFP72008ParticipantEUR 114,846
CORNERCorrelated Noise Errors in Quantum Information ProcessingFP72008ParticipantEUR 296,325
TELOMARKERIdentification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug developmentFP72008ParticipantEUR 311,000
GENINCAGenomic instability and genomic alterations in pre-cancerous lesions and/or cancerFP72008ParticipantEUR 322,132

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.